Tyrosylleucine is a dipeptide composed of tyrosine and leucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an 'Expected' metabolite. References: Moreira IP, Sasselli IR, Cannon DA, Hughes M, Lamprou DA, Tuttle T, Ulijn RV. Enzymatically activated emulsions stabilised by interfacial nanofibre networks. Soft Matter. 2016 Mar 7;12(9):2623-31. doi: 10.1039/c5sm02730f. Epub 2016 Feb 1. PubMed PMID: 26905042.

纯度：≥98%

CAS：17355-10-1